Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats In vivo.

CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein

Wright, S. D., Ramos, R., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,986 · see citing works

Pathogenetic Mechanisms of Septic Shock

Epstein, F. H., & Parrillo, J. E. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282008 · Cited by 1,548 · see citing works

Cachectin: More Than a Tumor Necrosis Factor

Epstein, F. H., Beutler, B., & Cerami, A. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702123160705 · Cited by 1,423 · see citing works

Septic Shock in Humans

Parrillo, J. E., Parker, M. M., Natanson, C., Suffredini, A. F., Danner, R. L., Cunnion, R. E., & Ognibene, F. P. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-3-227 · Cited by 1,188 · see citing works

The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.

Waage, A., Brandtzaeg, P., Halstensen, A. I., Kierulf, P., & Espevik, T. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.169.1.333 · Cited by 1,175 · see citing works

Distribution of organelles and membranes between hepatocytes and nonhepatocytes in the rat liver parenchyma. A stereological study.

Blouin, A., Bolender, R. P., & Weibel, E. R. (1977) · The Journal of Cell Biology · doi:10.1083/jcb.72.2.441 · Cited by 866 · see citing works

Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides

Morrison, D. C., & Jacobs, D. M. (1976) · Immunochemistry · doi:10.1016/0019-2791(76)90181-6 · Cited by 819 · see citing works

A new and improved microassay to determine 2-keto-3-deoxyoctonate in lipopolysaccharide of gram-negative bacteria

Karkhanis, Y. D., Zeltner, J. Y., Jackson, J. J., & Carlo, D. J. (1978) · Analytical Biochemistry · doi:10.1016/0003-2697(78)90260-9 · Cited by 704 · see citing works

In vivo protection against endotoxin by plasma high density lipoprotein.

Levine, D. M., Parker, T. S., Donnelly, T. M., Walsh, A., & Rubin, A. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.12040 · Cited by 485 · see citing works

Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS.

Wurfel, M. M., Kunitake, S. T., Lichenstein, H., Kane, J. P., & Wright, S. D. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.1025 · Cited by 442 · see citing works

The Clearance, Tissue Distribution, and Cellular Localization of Intravenously Injected Lipopolysaccharide in Rabbits

Mathison, J. C., & Ulevitch, R. J. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.123.5.2133 · Cited by 425 · see citing works

Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo.

Feingold, K. R., & Grünfeld, C. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113046 · Cited by 403 · see citing works

In vivo and in vitro uptake and degradation of acetylated low density lipoprotein by rat liver endothelial, Kupffer, and parenchymal cells.

Nagelkerke, J. F., Barto, K. P., & van Berkel, T. J. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44160-3 · Cited by 392 · see citing works

Reversible modification of arginine residues. Application to sequence studies by restriction of tryptic hydrolysis to lysine residues

Patthy, L., & Smith, E. L. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)41933-9 · Cited by 387 · see citing works

Lactoferrin is a lipid A-binding protein

Appelmelk, B. J., An, Y. Q., Geerts, M., Thijs, B. G., de Boer, H. A., MacLaren, D. M., Graaff, J., & Nuijens, J. H. (1994) · Infection and Immunity · doi:10.1128/iai.62.6.2628-2632.1994 · Cited by 362 · see citing works

Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance.

Feingold, K., Staprãns, I., Memon, R., Moser, A. H., Shigenaga, J. K., Doerrler, W. T., Dinarello, C. A., & Grünfeld, C. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41334-3 · Cited by 346 · see citing works

Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice.

Harris, H. W., Grünfeld, C., Kr, F., & Rapp, J. H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114765 · Cited by 321 · see citing works

New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides.

Ulevitch, R. J., Johnston, A. R., & Weinstein, D. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109610 · Cited by 298 · see citing works

Lipoprotein lipase suppression in 3T3-L1 cells by an endotoxin-induced mediator from exudate cells.

Kawakami, M., Pekala, P. H., Lane, M. D., & Cerami, A. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.3.912 · Cited by 267 · see citing works

In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia. Kinetics, Kupffer cell expression, and glucocorticoid effects.

Chensue, S. W., Terebuh, P., Remick, D. G., Scales, W. E., & Kunkel, S. L. (1991) · PubMed Central · Cited by 260 · see citing works

Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide

Elass, E., Roșeanu, A., Legrand, D., Trif, M., Salmon, V., Motaş, C., Montreuil, J., & Spik, G. (1995) · Biochemical Journal · doi:10.1042/bj3120839 · Cited by 250 · see citing works

Nature and Linkages of the Fatty Acids Present in the Lipid‐A Component of Salmonella Lipopolysaccharides

Rietschel, E., Gotter, H., Luderitz, O., & Westphal, O. (1972) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1972.tb01899.x · Cited by 241 · see citing works

Recognition of endotoxin by cells leading to transmembrane signaling

Ulevitch, R. J., & Tobias, P. S. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90043-4 · Cited by 238 · see citing works

Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo.

Machnicki, M., Zimecki, M., & Zagulski, T. (1993) · Europe PMC (PubMed Central) · Cited by 232 · see citing works

Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death.

Harris, H. W., Grünfeld, C., Feingold, K. R., Read, T. E., Kane, J. P., Jones, A. L., Eichbaum, E. B., Bland, G. F., & Rapp, J. H. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116259 · Cited by 214 · see citing works

Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood

Parker, T. S., Levine, D. M., Chang, J. C., Laxer, J., Coffin, C. C., & Rubin, A. L. (1995) · Infection and Immunity · doi:10.1128/iai.63.1.253-258.1995 · Cited by 211 · see citing works

Uptake by liver cells of endotoxin following its intravenous injection.

Dj, R., van der Meulen, J., Brouwer, A., Mj, H., Mauw, B. J., Jc, V. D. P., & Wisse, E. (1981) · PubMed · Cited by 188 · see citing works

Clearance Capacity of Rat Liver Kupffer, Endothelial, and Parenchymal Cells

Dalen, D. P. P.-V., Brouwer, A., & Knook, D. L. (1981) · Gastroenterology · doi:10.1016/s0016-5085(81)80009-1 · Cited by 186 · see citing works

The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide.

Lenten, B. J. V., Fogelman, A. M., Haberland, M. E., & Edwards, P. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2704 · Cited by 185 · see citing works

Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I

Flegel, W. A., Baumstark, M. W., Weinstock, C., Berg, A., & Northoff, H. (1993) · Infection and Immunity · doi:10.1128/iai.61.12.5140-5146.1993 · Cited by 169 · see citing works

Metabolism of protein-free lipid emulsion models of chylomicrons in rats

Redgrave, T. G., & Maranhão, R. C. (1985) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(85)90036-0 · Cited by 162 · see citing works

In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins

Emancipator, K., Csákó, G., & Elin, R. J. (1992) · Infection and Immunity · doi:10.1128/iai.60.2.596-601.1992 · Cited by 154 · see citing works

Selective liver targeting of antivirals by recombinant chylomicrons — a new therapeutic approach to hepatitis B

Rensen, P. C. N., van Dijk, M. C. M., Havenaar, E. C., Bijsterbosch, M. K., Kruijt, J. K., & van Berkel, T. J. C. (1995) · Nature Medicine · doi:10.1038/nm0395-221 · Cited by 147 · see citing works

Apolipoprotein E Effectively Inhibits Lipoprotein Lipase-mediated Lipolysis of Chylomicron-like Triglyceride-rich Lipid Emulsions and

Rensen, P. C. N., & van Berkel, T. J. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.14791 · Cited by 144 · see citing works

Time course of cellular distribution of endotoxin in liver, lungs and kidneys of rats.

Freudenberg, M. A., Freudenberg, N., & Galanos, C. (1982) · PubMed · Cited by 143 · see citing works

Hypertriglyceridemia Produced by Endotoxin: Role of Impaired Triglyceride Disposal Mechanisms

Kaufmann, R. L., Matson, C. F., & Beisel, W. R. (1976) · The Journal of Infectious Diseases · doi:10.1093/infdis/133.5.548 · Cited by 114 · see citing works

Effect of sepsis on VLDL kinetics: responses in basal state and during glucose infusion

Wolfe, R. R., Shaw, J. H., & Durkot, M. J. (1985) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1985.248.6.e732 · Cited by 112 · see citing works

Lactoferrin-lipopolysaccharide interactions. Effect on lactoferrin binding to monocyte/macrophage-differentiated HL-60 cells

Miyazawa, K., Mantel, C., Lü, L., Morrison, D. C., & Broxmeyer, H. E. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.2.723 · Cited by 103 · see citing works

The preparation and characterization of a radioiodinated bacterial lipopolysaccharide

Ulevitch, R. J. (1978) · Immunochemistry · doi:10.1016/0161-5890(78)90144-x · Cited by 103 · see citing works

Binding of Salmonella typhimurium lipopolysaccharides to rat high-density lipoproteins

Munford, R. S., Hall, C. L., & Dietschy, J. M. (1981) · Infection and Immunity · doi:10.1128/iai.34.3.835-843.1981 · Cited by 101 · see citing works

Plasma Lipopolysaccharide-binding Protein Is Found Associated with a Particle Containing Apolipoprotein A-I, Phospholipid, and Factor H-related Proteins

Park, C. T., & Wright, S. D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.18054 · Cited by 98 · see citing works

Interaction of Lactoferrin and Lipopolysaccharide (LPS): Effects on the Antioxidant Property of Lactoferrin and the Ability of LPS to Prime Human Neutrophils for Enhanced Superoxide Formation

Cohen, M. S., Mao, J., Rasmussen, G. T., Serody, J. S., & Britigan, B. E. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/166.6.1375 · Cited by 90 · see citing works

Human apolipoprotein E expression in Escherichia coli: structural and functional identity of the bacterially produced protein with plasma apolipoprotein E

Vogel, T., Weisgraber, K. H., Zeevi, M. I., Ben-Artzi, H., Levanon, A. Z., Rall, S. C., Innerarity, T. L., Hui, D. Y., Taylor, J. M., & Kanner, D. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8696 · Cited by 88 · see citing works

Chylomicrons enhance endotoxin excretion in bile

Read, T. E., Harris, H. W., Grünfeld, C., Feingold, K. R., Calhoun, M. C., Kane, J. P., & Rapp, J. H. (1993) · Infection and Immunity · doi:10.1128/iai.61.8.3496-3502.1993 · Cited by 73 · see citing works

Characteristics of chylomicron remnant uptake into rat liver

Huettinger, M., Retzek, H., Eder, M., & Goldenberg, H. (1988) · Clinical Biochemistry · doi:10.1016/s0009-9120(88)80093-6 · Cited by 72 · see citing works

High density lipoprotein catabolism before and after partial hepatectomy

van Tol, A., van Gent, T., Hooft, F. M. V., & Vlaspolder, F. (1978) · Atherosclerosis · doi:10.1016/0021-9150(78)90172-7 · Cited by 71 · see citing works

Lactosylated low density lipoprotein: a potential carrier for the site-specific delivery of drugs to Kupffer cells.

Bijsterbosch, M. K., Ziere, G. J., & van Berkel, T. J. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09320-4 · Cited by 68 · see citing works

The interaction in vivo of transferrin and asialotransferrin with liver cells

van Berkel, T. J. C., Dekker, C. J., Kruijt, J. K., & van Eijk, H. G. (1987) · Biochemical Journal · doi:10.1042/bj2430715 · Cited by 55 · see citing works

Effect of hypertriglyceridemia on endotoxin responsiveness in humans

van der Poll, T., Braxton, C. C., Coyle, S. M., Boermeester, M. A., Wang, J.-C., Jansen, P. M., Montegut, W. J., Calvano, S. E., Hack, C. E., & Lowry, S. F. (1995) · Infection and Immunity · doi:10.1128/iai.63.9.3396-3400.1995 · Cited by 55 · see citing works

Lactoferrin Is a Lipid A-Binding Protein

(1994) · Infection and Immunity · doi:10.1128/iai.62.10.4695-4695.1994 · Cited by 8 · see citing works

Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock

van Amersfoort, E. S., van Berkel, T. J. C., & Kuiper, J. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.3.379-414.2003 · Cited by 750 · see citing works

Dyslipidemia and inflammation: an evolutionary conserved mechanism

Esteve, E., Ricart, W., & Fernández-Real, J. M. (2005) · Clinical Nutrition · doi:10.1016/j.clnu.2004.08.004 · Cited by 492 · see citing works

The endotoxin hypothesis of neurodegeneration

Brown, G. C. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1564-7 · Cited by 457 · see citing works

Apolipoprotein E Induces Antiinflammatory Phenotype in Macrophages

Baitsch, D., Bock, H. H., Engel, T., Telgmann, R., Müller‐Tidow, C., Varga, G., Bot, M., Herz, J., Robenek, H., von Eckardstein, A., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.222745 · Cited by 361 · see citing works

Gut microbiota and diabetes: from pathogenesis to therapeutic perspective

Burcelin, R., Sérino, M., Chabo, C., Blasco‐Baqué, V., & Amar, J. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0333-6 · Cited by 256 · see citing works

A Novel Role for an Insect Apolipoprotein (Apolipophorin III) in β-1,3-Glucan Pattern Recognition and Cellular Encapsulation Reactions

Whitten, M. M. A., Tew, I., Lee, B. L., & Ratcliffe, N. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2177 · Cited by 222 · see citing works

Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting

Rensen, P. C. N., de Vrueh, R. L. A., Kuiper, J., Bijsterbosch, M. K., Biessen, E. A. L., & van Berkel, T. J. C. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00109-0 · Cited by 217 · see citing works

Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection

de Bont, N., Netea, M. G., Demacker, P. N. M., Verschueren, I., Kullberg, B. J., van Dijk, K. W., van der Meer, J. W. M., & Stalenhoef, A. F. H. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32147-7 · Cited by 210 · see citing works

APOε4 is associated with enhanced in vivo innate immune responses in human subjects

Gale, S. C., Gao, L., Mikacenic, C., Coyle, S. M., Rafaels, N., Murray Dudenkov, T., Madenspacher, J. H., Draper, D. W., Ge, W., Aloor, J. J., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.01.032 · Cited by 202 · see citing works

Lipopolysaccharide (LPS)-Binding Protein Mediates LPS Detoxification by Chylomicrons

Vreugdenhil, A. C. E., Rousseau, C. H., Härtung, T., Greve, J. W. M., Veer, C. V. ′., & Buurman, W. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1399 · Cited by 206 · see citing works

High-Density Lipoproteins in Sepsis and Septic Shock: Metabolism, Actions, and Therapeutic Applications

Wu, A., Hinds, C., & Thiemermann, C. (2004) · Shock · doi:10.1097/01.shk.0000111661.09279.82 · Cited by 199 · see citing works

Gut microbiota and immune crosstalk in metabolic disease

Burcelin, R. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.05.016 · Cited by 191 · see citing works

Gastrointestinal and hepatic mechanisms limiting entry and dissemination of lipopolysaccharide into the systemic circulation

Guerville, M., & Boudry, G. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00098.2016 · Cited by 189 · see citing works

Apolipoprotein E Protects Against Bacterial Lipopolysaccharide-induced Lethality

Van Oosten, M., Rensen, P. C. N., Van Amersfoort, E. S., Van Eck, M., Van Dam, A.-M., Brevé, J. J. P., Vogel, T., Panet, A., Van Berkel, T. J. C., & Kuiper, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009915200 · Cited by 186 · see citing works

Lipoproteins in inflammation and sepsis. I. Basic science

Murch, O., Collin, M., Hinds, C., & Thiemermann, C. (2006) · Intensive Care Medicine · doi:10.1007/s00134-006-0432-y · Cited by 179 · see citing works

Apolipoprotein E Suppresses the Type I Inflammatory Response In Vivo

Ali, K., Middleton, M. K., Puré, E., & Rader, D. J. (2005) · Circulation Research · doi:10.1161/01.res.0000187467.67684.43 · Cited by 179 · see citing works

Changes in HDL-associated apolipoproteins relate to mortality in human sepsis and correlate to monocyte and platelet activation

Barlage, S., Gnewuch, C., Liebisch, G., Wolf, Z., Audebert, F., Glück, T., Fröhlich, D., Krämer, B. K., Rothe, G., & Schmitz, G. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1609-y · Cited by 174 · see citing works

Antiinflammatory and Antiatherogenic Effects of the NF-κB Inhibitor Acetyl-11-Keto-β-Boswellic Acid in LPS-Challenged ApoE −/− Mice

Cuaz‐Pérolin, C., Billiet, L., Baugé, E., Copin, C., Scott‐Algara, D., Genze, F., Büchele, B., Syrovets, T., Simmet, T., & Rouis, M. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.155606 · Cited by 170 · see citing works

SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance

Cai, L., Ji, A., de Beer, F. C., Tannock, L. R., & van der Westhuyzen, D. R. (2008) · Journal of Clinical Investigation · doi:10.1172/jci31539 · Cited by 167 · see citing works

LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction

Vreugdenhil, A. C. E., Snoek, A. M. P., Veer, C. V. ′., Greve, J.-W. M., & Buurman, W. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10832 · Cited by 166 · see citing works

Implication of natural killer T cells in atherosclerosis development during a LPS‐induced chronic inflammation

Ostos, M. A., Recalde, D., Zakin, M. M., & Scott‐Algara, D. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02692-3 · Cited by 152 · see citing works

Changes in the concentration and composition of plasma lipoproteins during the acute phase response

Carpentier, Y. A., & Scruel, O. (2002) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200203000-00006 · Cited by 148 · see citing works

Apolipoproteins modulate the inflammatory response to lipopolysaccharide

Berbée, J. F. P., Havekes, L. M., & Rensen, P. C. N. (2005) · Journal of Endotoxin Research · doi:10.1179/096805105x35215 · Cited by 145 · see citing works

Lipoproteins inhibit macrophage activation by lipoteichoic acid

Grünfeld, C., Marshall, M. K., Shigenaga, J. K., Moser, A. H., Tobias, P. S., & Feingold, K. R. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33363-0 · Cited by 143 · see citing works

Immuno-microbiota cross and talk: The new paradigm of metabolic diseases

Burcelin, R., Garidou, L., & Pomié, C. (2012) · Seminars in Immunology · doi:10.1016/j.smim.2011.11.011 · Cited by 142 · see citing works

The endotoxin hypothesis of Alzheimer’s disease

Brown, G. C., & Heneka, M. T. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00722-y · Cited by 140 · see citing works

Emerging Roles of Apolipoprotein E and Apolipoprotein A-I in the Pathogenesis and Treatment of Lung Disease

Yao, X., Gordon, E. M., Figueroa, D. M., Barochia, A. V., & Levine, S. J. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0060tr · Cited by 132 · see citing works

ApoE Plasma Levels and Risk of Cardiovascular Mortality in Old Age

Mooijaart, S. P., Berbée, J. F. P., van Heemst, D., Havekes, L. M., de Craen, A. J. M., Slagboom, P. E., Rensen, P. C. N., & Westendorp, R. G. J. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030176 · Cited by 129 · see citing works

Acute inflammation and infection maintain circulating phospholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins

Kitchens, R. L., Thompson, P. A., Munford, R. S., & O’Keefe, G. E. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300228-jlr200 · Cited by 123 · see citing works

Human Apolipoprotein A-IV Reduces Secretion of Proinflammatory Cytokines and Atherosclerotic Effects of a Chronic Infection Mimicked by Lipopolysaccharide

Recalde, D., Ostos, M. A., Badell, E., García-Otín, A. L., Pidoux, J., Castro, G. R., Zakin, M. M., & Scott‐Algara, D. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000119353.03690.22 · Cited by 116 · see citing works

Detoxifying endotoxin: time, place and person

Munford, R. S. (2005) · Journal of Endotoxin Research · doi:10.1179/096805105x35161 · Cited by 150 · see citing works

Triglyceride-Rich Lipoproteins as Agents of Innate Immunity

Barcia, A. M., & Harris, H. W. (2005) · Clinical Infectious Diseases · doi:10.1086/432005 · Cited by 97 · see citing works

Apolipoprotein E Negatively Regulates House Dust Mite–induced Asthma via a Low-Density Lipoprotein Receptor–mediated Pathway

Yao, X., Fredriksson, K., Yu, Z., Xu, X., Raghavachari, N., Keeran, K. J., Nugent, G. Z., Kwak, M., Amar, M. J., Remaley, A. T., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201002-0308oc · Cited by 95 · see citing works

Reduction of Circulating Cholesterol and Apolipoprotein Levels during Sepsis

Fraunberger, P., Schaefer, S., Werdan, K., Walli, A. K., & Seidel, D. (1999) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1999.059 · Cited by 94 · see citing works

Review: The lipemia of sepsis: triglyceride-rich lipoproteins as agents of innate immunity

Harris, H. W., Gosnell, J. E., & Kumwenda, Z. L. (2000) · Journal of Endotoxin Research · doi:10.1177/09680519000060060301 · Cited by 93 · see citing works

On the role and fate of LPS-dephosphorylating activity in the rat liver

Tuin, A., der Vlag, A. H., van Loenen-Weemaes, A. M., Meijer, D. K. F., & Poelstra, K. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00147.2005 · Cited by 91 · see citing works

Advances in Intravenous Lipid Emulsions

Carpentier, Y., & Dupont, I. E. (2000) · World Journal of Surgery · doi:10.1007/s002680010267 · Cited by 83 · see citing works

Endogenous carriers and ligands in non-immunogenic site-specific drug delivery

Vyas, S. P., & Sihorkar, V. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00067-3 · Cited by 82 · see citing works

Febrile-Range Temperature Modifies Early Systemic Tumor Necrosis Factor Alpha Expression in Mice Challenged with Bacterial Endotoxin

Jiang, Q., DeTolla, L. J., van Rooijen, N., Singh, I. S., Fitzgerald, B., Lipsky, M. M., Kane, A. S., Cross, A. S., & Hasday, J. D. (1999) · Infection and Immunity · doi:10.1128/iai.67.4.1539-1546.1999 · Cited by 79 · see citing works

Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in Gram‐negative sepsis

Berbée, J. F. P., van der Hoogt, C. C., Kleemann, R., Schippers, E. F., Kitchens, R. L., van Dissel, J. T., Bakker‐Woudenberg, I. A. J. M., Havekes, L. M., & Rensen, P. C. N. (2006) · The FASEB Journal · doi:10.1096/fj.05-5639fje · Cited by 81 · see citing works

Lipopolysaccharide-binding molecules: transporters, blockers and sensors

Chaby, R. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4020-4 · Cited by 79 · see citing works

Endothelial FN (Fibronectin) Deposition by α5β1 Integrins Drives Atherogenic Inflammation

Al‐Yafeai, Z., Yurdagul, A., Peretik, J. M., Alfaidi, M., Murphy, P. A., & Orr, A. W. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311705 · Cited by 78 · see citing works

Learning from biology: synthetic lipoproteins for drug delivery

Huang, H., Cruz, W., Chen, J., & Zheng, G. (2014) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1308 · Cited by 75 · see citing works

Apolipoprotein E‐deficient mice have an impaired immune response to Klebsiella pneumoniae

Bont, D., Netea, Demacker, Kullberg, Meer, V. D., & Stalenhoef (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00715.x · Cited by 71 · see citing works

Infection and Alzheimer's Disease: The APOE ε4 Connection and Lipid Metabolism

Urosevic, N., & Martins, R. N. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13407 · Cited by 68 · see citing works

Hepatic uptake and deacylation of the LPS in bloodborne LPS-lipoprotein complexes

Shao, B., Munford, R. S., Kitchens, R. L., & Varley, A. W. (2012) · Innate Immunity · doi:10.1177/1753425912442431 · Cited by 65 · see citing works

Association of low-density lipoprotein receptor polymorphisms and outcome of hepatitis C infection

Hennig, B. J., Hellier, S. C., Frodsham, A. J., Zhang, L., Klenerman, P., Knapp, S., Wright, M., Thomas, H. C., Thursz, M. R., & Hill, A. V. S. (2002) · Genes and Immunity · doi:10.1038/sj.gene.6363883 · Cited by 65 · see citing works

Infection induces a positive acute phase apolipoprotein E response from a negative acute phase gene: role of hepatic LDL receptors*

Li, L., Thompson, P. A., & Kitchens, R. L. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800172-jlr200 · Cited by 63 · see citing works

The Central Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Septic Pathogen Lipid Transport and Clearance

Walley, K. R., Francis, G. A., Opal, S. M., Stein, E. A., Russell, J. A., & Boyd, J. H. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201505-0876ci · Cited by 58 · see citing works

Endogenous lipoproteins impact the response to endotoxin in humans

Harris, H. W., Johnson, J. A., & Wigmore, S. J. (2002) · Critical Care Medicine · doi:10.1097/00003246-200201000-00004 · Cited by 56 · see citing works

Impact of sepsis-induced changes in plasma on LPS interactions with monocytes and plasma lipoproteins: roles of soluble CD14, LBP, and acute phase lipoproteins

Kitchens, R. L., & Thompson, P. A. (2003) · Journal of Endotoxin Research · doi:10.1177/09680519030090020701 · Cited by 52 · see citing works

Apolipoprotein E Plays a Key Role against Cryptosporidial Infection in Transgenic Undernourished Mice

de Azevedo, O. G. R., Bolick, D. T., Roche, J. K., Pinkerton, R., Lima, A. Â. M., Vitek, M. P., Warren, C. A., Oriá, R. B., & Guerrant, R. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089562 · Cited by 51 · see citing works

Lipopolysaccharide (LPS)-Binding Synthetic Peptides Derived from Serum Amyloid P Component Neutralize LPS

de Haas, C. D., van der Zee, R., Benaissa-Trouw, B., van Kessel, K. V., Verhoef, J., & van Strijp, J. V. (1999) · Infection and Immunity · doi:10.1128/iai.67.6.2790-2796.1999 · Cited by 51 · see citing works

Apolipoprotein E COG 133 mimetic peptide improves 5-fluorouracil-induced intestinal mucositis

de Azevedo, O. G. R., Oliveira, R. A. C., Oliveira, B. C., Zaja‐Milatovic, S., de Araújo, C. V., Wong, D. V. T., Costa, T. B., Lucena, H. B. M., Lima‐Júnior, R. C. P., Ribeiro, R. A., et al. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-35 · Cited by 45 · see citing works

Protein-free phospholipid emulsion treatment improved cardiopulmonary function and survival in porcine sepsis

Goldfarb, R. D., Parker, T. S., Levine, D. M., Glock, D., Akhter, I., Alkhudari, A., McCarthy, R. J., David, E. M., Gordon, B. R., Saal, S. D., et al. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00285.2002 · Cited by 44 · see citing works

Host defenses against metabolic endotoxaemia and their impact on lipopolysaccharide detection

Faraj, T. A., McLaughlin, C. L., & Erridge, C. (2017) · International Reviews of Immunology · doi:10.1080/08830185.2017.1280483 · Cited by 44 · see citing works

Presence of the apolipoprotein E-ε4 allele is associated with an increased risk of sepsis progression

Shao, Y., Zhao, T., Zhang, W., He, J., Lu, F., Cai, Y., Lai, Z., Wei, N., Liang, C., Liu, L., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-72616-0 · Cited by 42 · see citing works

Apolipoprotein A-II augments monocyte responses to LPS by suppressing the inhibitory activity of LPS-binding protein

Thompson, P. A., Berbée, J. F. P., Rensen, P. C. N., & Kitchens, R. L. (2008) · Innate Immunity · doi:10.1177/1753425908099171 · Cited by 41 · see citing works

A Novel Role for CETP as Immunological Gatekeeper: Raising HDL to Cure Sepsis?

Blauw, L. L., Wang, Y., van Dijk, K. W., & Rensen, P. C. N. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.01.003 · Cited by 40 · see citing works

Lipopolysaccharide transport from the peritoneal cavity to the blood: is it controlled by the vagus nerve?

Romanovsky, A. A., Ivanov, A. I., Lenczowski, M. J. P., KULCHITSKY, V. A., van Dam, A., Poole, S., HOMER, L. D., & Tilders, F. J. H. (2000) · Autonomic Neuroscience · doi:10.1016/s1566-0702(00)00232-0 · Cited by 39 · see citing works

Targeted deletion of endothelial lipase increases HDL particles with anti-inflammatory properties both in vitro and in vivo

Hara, T., Ishida, T., Kojima, Y., Tanaka, H., Yasuda, T., Shinohara, M., Toh, R., & Hirata, K. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m008417 · Cited by 38 · see citing works

ABCA1 promotes the efflux of bacterial LPS from macrophages and accelerates recovery from LPS-induced tolerance

Thompson, P. A., Gauthier, K. C., Varley, A. W., & Kitchens, R. L. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m007435 · Cited by 36 · see citing works

Adaptive immunity against gut microbiota enhances apoE-mediated immune regulation and reduces atherosclerosis and western-diet-related inflammation

Saita, D., Ferrarese, R., Foglieni, C., Esposito, A., Canu, T., Perani, L., Ceresola, E. R., Visconti, L. M., Burioni, R., Clementi, M., et al. (2016) · Scientific Reports · doi:10.1038/srep29353 · Cited by 36 · see citing works

Triglycerides Potentiate the Inflammatory Response in Rat Kupffer Cells

Budick-Harmelin, N., Dudás, J., Demuth, J. E., Madar, Z., Ramadori, G. P., & Tirosh, O. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1876 · Cited by 35 · see citing works

APOE Genotype Affects Outcome in a Murine Model of Sepsis: Implications for a New Treatment Strategy

Wang, H., Christensen, D. J., Vitek, M. P., Sullivan, P. M., & Laskowitz, D. T. (2009) · Anaesthesia and Intensive Care · doi:10.1177/0310057x0903700111 · Cited by 34 · see citing works

Endotoxin promotes preferential periportal upregulation of VLDL secretion in the rat liver

Aspichueta, P., Pérez, S., Ochoa, B., & Fresnedo, O. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500003-jlr200 · Cited by 32 · see citing works

Alanyl-glutamine attenuates 5-fluorouracil-induced intestinal mucositis in apolipoprotein E-deficient mice

Araújo, C. V., Lazzarotto, C. R., de Aquino, C. C., Figueiredo, Í. L., Costa, T. B., Alves, L. G. R. D. D. S. E., Ribeiro, R. A., Bertolini, L. R., Lima, A. Â. M., Brito, G. A. D. C., et al. (2015) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20144360 · Cited by 29 · see citing works

Analysis of apolipoprotein genes and their involvement in disease response of channel catfish after bacterial infection

Yang, Y., Fu, Q., Zhou, T., Li, Y., Liu, S., Zeng, Q., Wang, X., Jin, Y., Tian, C., Qin, Z., et al. (2016) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2016.09.007 · Cited by 28 · see citing works

Liver X Receptor Alpha Associates With Human Life Span

Mooijaart, S. P., Kuningas, M., Westendorp, R. G. J., Houwing‐Duistermaat, J. J., Slagboom, P. E., Rensen, P. C. N., & van Heemst, D. (2007) · The Journals of Gerontology Series A · doi:10.1093/gerona/62.4.343 · Cited by 28 · see citing works

Hepatocyte-specific IKK-β activation enhances VLDL-triglyceride production in APOE*3-Leiden mice

van Diepen, J. A., Wong, M. C., Guigas, B., Bos, J. E., Stienstra, R., Hodson, L., Shoelson, S. E., Berbée, J. F. P., Rensen, P. C. N., Romijn, J. A., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m010405 · Cited by 26 · see citing works

Plasma Apolipoprotein CI Protects Against Mortality From Infection in Old Age

Berbée, J. F. P., Mooijaart, S. P., de Craen, A. J. M., Havekes, L. M., van Heemst, D., Rensen, P. C. N., & Westendorp, R. G. J. (2008) · The Journals of Gerontology Series A · doi:10.1093/gerona/63.2.122 · Cited by 25 · see citing works

Tyrosine fluorescence analysis of apolipophorin III–lipopolysaccharide interaction

Leon, L. J., Pratt, C. C., Vásquez, L. J., & Weers, P. M. M. (2006) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.05.009 · Cited by 24 · see citing works

An expanding role for apolipoprotein E in sepsis and inflammation

Chuang, K., Elford, E. L., Tseng, J., Leung, B., & Harris, H. W. (2010) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2009.10.017 · Cited by 24 · see citing works

NKT Cells: The Culprits of Sepsis?

Leung, B., & Harris, H. W. (2010) · Journal of Surgical Research · doi:10.1016/j.jss.2010.09.038 · Cited by 23 · see citing works

Preoperative apolipoprotein CI levels correlate positively with the proinflammatory response in patients experiencing endotoxemia following elective cardiac surgery

Schippers, E. F., Berbée, J. F. P., Disseldorp, I. M. L.-V., Versteegh, M. I. M., Havekes, L. M., Rensen, P. C. N., & van Dissel, J. T. (2008) · Intensive Care Medicine · doi:10.1007/s00134-008-1077-9 · Cited by 22 · see citing works

Serum lipoproteins attenuate macrophage activation and Toll-Like Receptor stimulation by bacterial lipoproteins

Bas, S., James, R. W., & Gabay, C. (2010) · BMC Immunology · doi:10.1186/1471-2172-11-46 · Cited by 19 · see citing works

Microbiote intestinal et dialogue immunitaire au cours de la maladie métabolique

Burcelin, R. (2017) · Biologie Aujourd hui · doi:10.1051/jbio/2017008 · Cited by 18 · see citing works

Hyperlipoproteinemic low-density lipoprotein receptor-deficient mice are more susceptible to sepsis than corresponding wild-type mice

Lanza‐Jacoby, S., Miller, S., Jacob, S., Heumann, D., Minchenko, О. H., & Flynn, J. T. (2003) · Journal of Endotoxin Research · doi:10.1177/09680519030090060701 · Cited by 18 · see citing works

Clinical use of lipid emulsions

Dupont, I. E., & Carpentier, Y. (1999) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-199903000-00008 · Cited by 18 · see citing works

Insertion of apoLp-III into a lipid monolayer is more favorable for saturated, more ordered, acyl-chains

Rathnayake, S. S., Mirheydari, M., Schulte, A. T., Gillahan, J. E., Gentit, T., Phillips, A., Okonkwo, R. K., Burger, K. N. J., Mann, E. K., Vaknin, D., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.09.020 · Cited by 16 · see citing works

The APOE ε4 allele is associated with a reduction in FEV1/FVC in women: A cross-sectional analysis of the Long Life Family Study

Kulminski, A. M., Barochia, A. V., Loika, Y., Raghavachari, N., Arbeev, K. G., Wojczynski, M. K., Thyagarajan, B., Vardarajan, B. N., Christensen, K., Yashin, A. I., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206873 · Cited by 16 · see citing works

Modulation of apolipoprotein E and interleukin-1β in the aging liver

Gee, J. R., Ding, Q., & Keller, J. N. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.01.010 · Cited by 16 · see citing works

Apolipoproteins as context-dependent regulators of lung inflammation

Figueroa, D. M., Gordon, E. M., Yao, X., & Levine, S. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813553-2.00013-0 · Cited by 14 · see citing works

Immunoinflammatory role of apolipoprotein E4 in malnutrition and enteric infections and the increased risk for chronic diseases under adverse environments

Freitas, R. S., Roque, C. R., Matos, G. A., Belayev, L., de Azevedo, O. G. R., Alvarez-Leite, J. I., Guerrant, R. L., & Oriá, R. B. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab063 · Cited by 13 · see citing works

Comparison of anti-endotoxin activity of apoE and apoA mimetic derivatives of a model amphipathic peptide 18A

Sharifov, O. F., Nayyar, G., Ternovoi, V. V., Palgunachari, M. N., Garber, D. W., Anantharamaiah, G. M., & Gupta, H. (2013) · Innate Immunity · doi:10.1177/1753425913514621 · Cited by 12 · see citing works

LPS-Induced Systemic Inflammation Does Not Alter Atherosclerotic Plaque Area or Inflammation in APOE3∗LEIDEN Mice in the Early Phase Up to 15 Days

Fuijkschot, W. W., Morrison, M. C., Zethof, I. P. A., Krijnen, P. A. J., Kleemann, R., Niessen, H. W. M., & Smulders, Y. M. (2017) · Shock · doi:10.1097/shk.0000000000001026 · Cited by 11 · see citing works

Effect of LPS on basal and induced apo E secretion by 25‐OH chol and 9cRA in differentiated CaCo‐2

Piquer, B. R., Nazih, H., Neunlist, M., Huvelin, J., & Bard, J. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10786 · Cited by 11 · see citing works

Transient increase in atherosclerotic plaque macrophage content following Streptococcus pneumoniae pneumonia in ApoE-deficient mice

Bazaz, R., Marriott, H. M., Wright, C., Chamberlain, J., West, L. E., Gelsthorpe, C., Heath, P. R., Maleki-Dizaji, A., Francis, S., & Dockrell, D. H. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1090550 · Cited by 10 · see citing works

High-density lipoprotein: a biomarker and therapeutic target in sepsis

Li, M., Barros-Pinkelnig, M., Arbous, M. S., Christoffersen, C., Rensen, P. C. N., & Kooijman, S. (2025) · Critical Care · doi:10.1186/s13054-025-05702-2 · Cited by 9 · see citing works

Deactivation of the lipopolysaccharide antagonist eritoran (E5564) by high-density lipoprotein-associated apolipoproteins

Fleischer, J. G., Rossignol, D., Francis, G. A., Chan, T., Lynn, M., & Wasan, K. M. (2011) · Innate Immunity · doi:10.1177/1753425910394395 · Cited by 9 · see citing works

Induction of cytokine tolerance requires internalization of Chylomicron-Bound LPS into hepatocytes

Kasravi, F. B., Brecht, W. J., Weisgraber, K. H., & Harris, H. W. (2003) · Journal of Surgical Research · doi:10.1016/s0022-4804(03)00197-5 · Cited by 9 · see citing works

Microbiota and Alzheimer’s disease: mechanistic insights from a multi-organ perspective

Liao, J., Mou, H., Luo, S., Shen, L., & Jiao, B. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00541-9 · Cited by 10 · see citing works

Potential of Lipoprotein-Based Nanoparticulate Formulations for the Treatment of Eye Diseases

Fukuda, R., & Murakami, T. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00858 · Cited by 8 · see citing works

Disruption of Phospholipid Transfer Protein–Mediated High-Density Lipoprotein Maturation Reduces Scavenger Receptor BI Deficiency–Driven Atherosclerosis Susceptibility Despite Unexpected Metabolic Complications

Hoekstra, M., van der Sluis, R. J., Hildebrand, R. B., Lammers, B., Zhao, Y., Praticò, D., van Berkel, T. J. C., Rensen, P. C. N., Kooijman, S., Jauhiainen, M., et al. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.313862 · Cited by 8 · see citing works

Lipoprotein-bound LPS induces cytokine tolerance in hepatocytes

Harris, H. W., & Kasravi, F. B. (2003) · Journal of Endotoxin Research · doi:10.1177/09680519030090010501 · Cited by 7 · see citing works

The effect of poloxamer 407 on the functional properties of HDL in mice

Yasuda, T., Johnston, T. P., Shinohara, M., Inoue, M., & Ishida, T. (2012) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01444.x · Cited by 6 · see citing works

Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock

van Amersfoort, E. S., & Kuiper, J. (2007) · CRC Press eBooks · doi:10.3109/9781420020595-21 · Cited by 6 · see citing works

Apolipoprotein E-containing lipoproteins and their extracellular interactions with LRP1 affect LPS-induced inflammation

Akahane, S., Matsuura, H., Kaido, T., Usami, Y., Ishimine, N., Uehara, T., & Yamauchi, K. (2024) · Biological Chemistry · doi:10.1515/hsz-2024-0018 · Cited by 5 · see citing works

Apolipoprotein E3 and E4 isoforms exhibit differing effects in countering endotoxins

Puthia, M., Marzinek, J. K., Veselá, K., Larsson, A., Schmidtchen, A., Bond, P. J., & Petrlová, J. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108236 · Cited by 5 · see citing works

Rensen et al.

Invest, J. C., Recombinant, H., Redirects, A. E., Kupffer, L., & Rensen, P. C. N. (2016)

Secretion-recapture process of apolipoprotein E in hepatic uptake of chylomicron remnants in transgenic mice.

Shimano, H., Namba, Y., Ohsuga, J.-I., Kawamura, M., Yamamoto, K., Shimada, M., Gotoda, T., Harada, K., Yazaki, Y., & Yamada, N. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117218 · Cited by 57 · see citing works

Hepatic lipase treatment of chylomicron remnants increases exposure of apolipoprotein E.

Brasaemle, D. L., Cornely-Moss, K., & Bensadoun, A. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40737-0 · Cited by 53 · see citing works

Chylomicrons alter the hepatic distribution and cellular response to endotoxin in rats

Harris, H. W., Rockey, D. C., & Chau, P. (1998) · Hepatology · doi:10.1002/hep.510270521 · Cited by 38 · see citing works

Rapid initial removal of chylomicron remnants by the mouse liver does not require hepatically localized apolipoprotein E

Yu, K. C.-W., Jiang, Y., Chen, W., & Cooper, A. D. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31965-9 · Cited by 15 · see citing works